Stilla Technologies is a French company with over 100 employees, dedicated to the Crystal Digital PCR™, with recognised expertise in this technology. Its first shareholder is Illumina Venture.
With a mission to provide advanced, high-precision genetic testing and analysis solutions to facilitate and accelerate research and therapy, Stilla Technologies is constantly evolving and innovating.
The naica® system covers all stages of the workflow and is distinguished by its ease of use thanks to ready-to-use consumables, a multiplexing capability unique in the market and quality control over all stages of the workflow of your experience.
The main features of the six-colour Prism6 are as follows:
